Active ingredients: follitropin beta
What it is used for
In the female: Anovulatory infertility and; Controlled ovarian hyperstimulation to induce the development of multiple follicles in medically assisted reproduction programs (e.g. in vitro fertilisation and related procedures). In the male: For the treatment of deficient spermatogenesis due to hypogonadotrophic hypogonadism.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Subcutaneous
- Store at 2 to 8 degrees Celsius
- Do not Freeze
- Lifetime is 3 Years.
Always read the label. If symptoms persist see your healthcare professional.
Clear colourless aqueous solution in glass cartridge
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is Schedule 4: Prescription Only Medicine.
Is this medicine subsidised?
This medicine is subsidised which may make it cheaper. To learn more about this subsidy, visit the Phamaceutical Benefits Scheme (PBS) website
Pregnant or planning a pregnancy?
For the active ingredient follitropin beta
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf)
Puregon Solution for injection - myDr.com.au
Puregon Solution for injection - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome | Cochrane
Read more on Cochrane (Australasian Centre) website